Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus lidocaine for bilateral mandibular third molar surgery
IRCT20181023041425N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of ropivacaine, lidocaine and epinephrine in acute pain (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Bleeding during surgery, Pain during surgery and 1 more. Started Dec 2021; status: completed.
02
Drugs
ropivacainelidocaineepinephrine
03
Conditions
acute pain
Beyond the preview
Go deeper on IRCT20181023041425N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181023041425N3.